Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intec Pharma Ord Shr (NTEC)

Intec Pharma Ord Shr (NTEC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,087
  • Shares Outstanding, K 69,265
  • Annual Sales, $ 0 K
  • Annual Income, $ -47,600 K
  • 60-Month Beta 0.75
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.02
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.26
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/14/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.06
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +83.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2620 +10.69%
on 07/09/20
0.3900 -25.64%
on 06/16/20
-0.1176 (-28.85%)
since 06/10/20
3-Month
0.2000 +45.00%
on 04/14/20
0.4890 -40.70%
on 06/09/20
+0.0830 (+40.10%)
since 04/09/20
52-Week
0.1324 +119.03%
on 03/18/20
4.3000 -93.26%
on 07/11/19
-3.8800 (-93.05%)
since 07/10/19

Most Recent Stories

More News
Intec Pharma Ltd. (NTEC) Upgraded to Strong Buy: Here's Why

Intec Pharma Ltd. (NTEC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

NTEC : 0.2900 (+5.42%)
Implied Volatility Surging for Intec Pharma (NTEC) Stock Options

Investors need to pay close attention to Intec Pharma (NTEC) stock based on the movements in the options market lately.

NTEC : 0.2900 (+5.42%)
Intec Pharma to Present at Jefferies Virtual Healthcare Conference

, /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company management will present at the Jefferies Virtual Healthcare Conference.

NTEC : 0.2900 (+5.42%)
Intec Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update

, /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the first quarter ended and provides a corporate update. 

NTEC : 0.2900 (+5.42%)
Intec Pharma Announces $5.0 Million Registered Direct Offering

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company"), today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale...

NTEC : 0.2900 (+5.42%)
Intec Pharma Reports Fourth Quarter and Year End 2019 Financial Results and Corporate Update

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the fourth quarter and year ended December 31, 2019 and provides a corporate update.

NTEC : 0.2900 (+5.42%)
Intec Pharma to Participate at Three Investment Conferences in March

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences in March.

NTEC : 0.2900 (+5.42%)
CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors

CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced the appointment of Roger J. Pomerantz, M.D., F.A.C.P. to its Board of Directors as Chairman, effective immediately....

NTEC : 0.2900 (+5.42%)
MRK : 76.73 (+0.05%)
MCRB : 4.51 (-18.00%)
CLGN : 9.01 (-4.15%)
Intec Pharma Announces Pricing of $6.5 Million Public Offering

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announced the pricing of its previously announced underwritten public offering of 16,250,000 ordinary shares (which includes pre-funded...

NTEC : 0.2900 (+5.42%)
Intec Pharma Announces Proposed Public Offering

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announced that it intends to offer and sell a combination of ordinary shares (or pre-funded warrants to purchase ordinary shares in lieu...

NTEC : 0.2900 (+5.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade NTEC with:

Business Summary

Intec Pharma Ltd. is a biopharmaceutical company. The company focused on developing drugs through proprietary Accordion Pill platform technology. Its product candidates in clinical trial stages consists of Accordion Pill Carbidopa/Levodopa developed for the indication of treatment of Parkinson's disease...

See More

Key Turning Points

2nd Resistance Point 0.3221
1st Resistance Point 0.3061
Last Price 0.2900
1st Support Level 0.2728
2nd Support Level 0.2555

See More

52-Week High 4.3000
Fibonacci 61.8% 2.7080
Fibonacci 50% 2.2162
Fibonacci 38.2% 1.7244
Last Price 0.2900
52-Week Low 0.1324

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar